	US 12,226,442 B2
	*Composition comprising Nigella sativa* oil and surface-active agents**
Mor Zeilkha, Ramat Gan (IL)
Assigned to N.S. OILS LTD., Kibbutz Sa'ad (IL)
Appl. No. 17/291,545
Filed by N.S. OILS LTD., Kibbutz Sa'ad (IL)
PCT Filed Nov. 7, 2019, PCT No. PCT/IL2019/051221 § 371(c)(1), (2) Date May 5, 2021, PCT Pub. No. WO2020/095307, PCT Pub. Date May 14, 2020.
Claims priority of provisional application 62/757,187, filed on Nov. 8, 2018.
Prior Publication US 2021/0393727 A1, Dec. 23, 2021
Int. Cl. A61K 36/71 (2006.01); A61K 31/122 (2006.01); A61K 47/22 (2006.01); A61K 47/24 (2006.01); A61P 3/04 (2006.01); A61P 3/06 (2006.01); A61P 9/12 (2006.01)

CPC A61K 36/71 (2013.01) [A61K 31/122 (2013.01); A61K 47/22 (2013.01); A61K 47/24 (2013.01); A61P 3/04 (2018.01); A61P 3/06 (2018.01); A61P 9/12 (2018.01)]

8 Claims

1. A composition suitable for treating high blood pressure, comprising synergistically effective amounts of thymoquinone (TQ) from Nigella sativa oil; D-α-Tocopherol polyethylene glycol succinate (TPGS); and isolecithin and/or lecithin.